BMNDF Biomind Labs Inc.

USD 0.11 0.00 0
Icon

Biomind Labs Inc. (BMNDF) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.11

0.00 (0.00)%

USD 0.03B

N/A

N/A

N/A

Icon

BMNDF

Biomind Labs Inc. (USD)
COMMON STOCK | OTC
USD 0.11
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.03B

N/A

USD 0.11

Biomind Labs Inc. (BMNDF) Stock Forecast

N/A

Based on the Biomind Labs Inc. stock forecast from 0 analysts, the average analyst target price for Biomind Labs Inc. is not available over the next 12 months. Biomind Labs Inc.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Biomind Labs Inc. is Bearish, which is based on 1 positive signals and 5 negative signals. At the last closing, Biomind Labs Inc.’s stock price was USD 0.11. Biomind Labs Inc.’s stock price has changed by +0.00% over the past week, -67.65% over the past month and -78.85% over the last year.

No recent analyst target price found for Biomind Labs Inc.
No recent average analyst rating found for Biomind Labs Inc.

Company Overview Biomind Labs Inc.

Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the...Read More

https://www.biomindlabs.com

Building Ceibo Of. 002, Canelones, Uruguay

5

December

USD

USA

Adjusted Closing Price for Biomind Labs Inc. (BMNDF)

Loading...

Unadjusted Closing Price for Biomind Labs Inc. (BMNDF)

Loading...

Share Trading Volume for Biomind Labs Inc. Shares

Loading...

Compare Performance of Biomind Labs Inc. Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BMNDF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Biomind Labs Inc. (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NONOF
Novo Nordisk A/S +3.76 (+3.07%) USD564.56B 46.25 4.92

ETFs Containing BMNDF

Symbol Name BMNDF's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Biomind Labs Inc. (BMNDF) Stock

Stock Target Advisor's fundamental analysis for Biomind Labs Inc.'s stock is Bearish.

Unfortunately we do not have enough data on BMNDF's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BMNDF's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on BMNDF's stock to indicate if its overvalued.

The last closing price of BMNDF's stock was USD 0.11.

The most recent market capitalization for BMNDF is USD 0.03B.

Unfortunately we do not have enough analyst data on BMNDF's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Biomind Labs Inc.'s stock.

As per our most recent records Biomind Labs Inc. has 5 Employees.

Biomind Labs Inc.'s registered address is Building Ceibo Of. 002, Canelones, Uruguay. You can get more information about it from Biomind Labs Inc.'s website at https://www.biomindlabs.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...